ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
Expert Analysis of Durvalumab + Olaparib/Paclitaxel in High-Risk HER2- Stage II/III BC: Does the Addition of PD-L1 and PARP Inhibitors to SoC Chemo Improve PCR?
By
ecancer
FEATURING
Lajos Pusztai
By
ecancer
FEATURING
Lajos Pusztai
Login to view comments.
Click here to Login
